Trump threatens 200% tariffs on generic drugs in 2028, wants manufacturing to move to US

“But using 2028 as a pressure tactic is obviously not possible,” Varma said. “So our current trend, even within our portfolio companies, is to find some sort of land base and make sure there’s some production going on. But given the sheer volume of what the U.S. consumes today, that’s a long way off.”